but not likely. The pressure to develop a vaccine - or at least a very effective therapy like using monoclonal antibodies - is extremely high. Most people survi

but not likely. The pressure to develop a vaccine - or at least a very effective therapy like using monoclonal antibodies - is extremely high. Most people survive COVID19, so there must be either a way to trigger a proper immune response or to at least rebuild parts of their response. We‘re currently doing a lot of very advanced science in all related fields in parallel and I think that we can be very sure that we‘ll come up with multiple useful solutions within two years or so. And with a lot of general advancements to scale out processes that have been done on small scales until now. That does not mean that we‘ll be back to what used to be “normal“, though.